VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
COR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CORCencora, Inc.
$333.56$64.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCORCash Flow

Cencora, Inc. (COR) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow to net income ranged from -9.22 to 295.80 across ten quarters and free cash flow margins swung between -3.5 and 4.3 percent, indicating cash generation is driven by working capital timing while acquisitions such as the $4.7B outflow in 2026Q2 absorbed significant capital.

Income StatementBalance SheetCash FlowRatios

COR Cash Flow Statement

Annual statement

COR Cash Flow Statement

Cencora, Inc. (COR) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricSep'26Sep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97
Cash from Operations4.79B3.88B3.48B3.91B2.7B2.67B2.21B2.34B1.41B1.49B3.18B3.92B1.46B788.13M1.31B1.17B1.11B783.76M737.07M1.21B807.26M1.53B825.08M354.81M535.93M-40M216.58M3M125.9M-9.3M
Operating CF Margin %1.42%1.21%1.19%1.49%1.13%1.25%1.16%1.31%0.84%0.97%2.16%2.88%1.22%0.9%1.64%1.46%1.42%1.09%1.05%1.83%1.32%2.8%1.55%0.71%1.18%-0.25%1.86%0.03%1.45%-0.12%
Operating CF Growth %23.61%11.2%-10.91%44.7%1.37%20.82%-5.84%66.08%-5.21%-53.15%-18.92%167.94%85.65%-39.63%11.77%5.35%41.45%6.34%-38.98%49.63%-47.12%85.03%132.54%-33.79%1439.68%-118.47%7119.33%-97.62%1453.76%-123.25%
Net Income3.5B1.57B1.52B1.75B1.67B1.54B-3.4B854.13M1.62B414.48M1.43B-134.89M284.03M493.44M708.19M706.62M636.75M511.85M469.06M493.77M467.71M264.64M468.39M441.23M344.94M123.8M99.01M70.9M50.5M47.4M
Depreciation & Amortization01.07B1.12B980.85M709.84M514.79M401.62M488.54M499.64M422.92M392.17M249.6M192.73M170.79M147.19M125.94M104.17M94.32M95.88M104.34M96.93M90.88M87.09M80.44M66.58M24.71M17.42M19.9M16.6M14.3M
Stock-Based Compensation0147.96M148M124.62M93.4M99.59M74.41M58.87M62.32M62.21M64.99M60.94M43.11M36.27M26.12M28.36M30.84M27.14M000000000000
Deferred Taxes059.86M-102.32M-118.86M196.18M334.87M-1.54B28.54M-795.52M319.07M-130.93M22.73M39.31M25.57M60.64M195M-135.02M84.32M62.11M13.19M92.08M17.03M48.88M127.16M45.85M24.33M25.82M11.3M19.2M-5M
Other Non-Cash Items603.64M995.64M502.21M304.89M176.79M-194.59M11.14M550.55M199.78M-131.7M195.9M951.38M468.24M200.04M61.98M44.66M280.66M44.57M72.21M78.2M32.41M174.38M15.49M63.59M77.6M42.05M10.34M13.9M11.3M11.5M
Working Capital Changes685.11M35.42M298.69M874.54M-139.66M367.32M6.66B363.38M-170.72M402.02M1.23B2.77B435.73M-137.99M301.33M67.36M191.21M21.57M37.8M518.4M118.12M979.7M205.23M-357.61M952K-254.9M63.98M-113M28.3M-77.5M
Change in Receivables-1.49B-1.92B-2.78B-2.71B-1.66B-930.08M-1.63B-1.24B-657.77M-1.28B-912.72M-1.48B-938.29M-2.31B41.67M-35.46M61.16M-457.77M8.74M-229.33M0-392.77M-267.39M0000000
Change in Inventory-1.34B-1.27B-1.48B-2.18B-665.37M-1.12B-1.62B-167.99M-4.92M-431.45M-907.02M-836.38M-956.51M-1.49B-200.11M-272.29M-242.97M-765.01M-8.01M285.74M-349.54M1.07B916.3M-278.39M-362.19M-726.14M-327.35M-289.1M147.6M-271.8M
Change in Payables4.01B3.69B4.97B6.1B3.32B2.05B3.3B1.56B859.04M1.47B3.01B5.13B2.32B3.82B420.57M378.92M395.01M1.24B53.68M468.24M0311.42M-432.02M0000000
Cash from Investing-5.8B-4.98B-618.1M-2.6B-368.44M-6.14B-379.87M-375.83M-1.11B-498.04M-3.17B-2.93B-384.15M117.26M-947.95M-212.42M-184.37M-148.35M163.42M-674.44M-42.7M-152.31M-242.22M-201.81M-202.81M117.49M-21.49M-16.8M-8.1M-144.9M
Capital Expenditures-909.5M-667.98M-487.17M-458.36M-496.32M-438.22M-369.68M-310.22M-336.41M-466.4M-464.62M-231.59M-264.46M-202.45M-164.04M-167.95M-184.63M-145.84M-137.31M-118.05M-113.13M-203.38M-189.28M-90.55M-64.16M-23.36M-16.62M-15.8M-10.4M-15.9M
CapEx % of Revenue0.27%0.21%0.17%0.17%0.21%0.2%0.19%0.17%0.2%0.3%0.32%0.17%0.22%0.23%0.21%0.21%0.24%0.2%0.2%0.18%0.18%0.37%0.36%0.18%0.14%0.14%0.14%0.16%0.12%0.2%
Acquisitions-4.99B-4.29B-100.2M-2.15B120.28M-5.73B-56.08M-63.95M-785.3M-61.65M-2.75B-2.63B-117.79M329.98M-775.67M-45.38M0-1.48M-169.23M-170.09M-296.22M-4.4M-68.88M-111.98M-136.22M133.82M-3.03M000
Investments------------------------------
Other Investing142.91M-17.44M-30.72M9M7.6M22.3M-267.71M-1.66M10.6M52.5M5.12M-211.54M-148.57M-10.27M-8.24M916K264K-146.97M1.88M13.28M77.78M55.48M15.94M726K-2.43M7.04M-1.84M-1M2.3M-129M
Cash from Financing1.65B2.25B-2.33B-2.22B-1.75B1.95B-603.62M-1.09B-242.87M-1.31B565.07M-630.28M-501.49M-740.99M-1.12B-787.72M-275.44M-504.16M-662.58M-1.15B-469.85M-929.99M-511.55M-16.31M32.6M99.32M-133.77M24.8M-129.4M148.7M
Debt Issued (Net)3.25B3.2B-385.45M-623.26M-923.1M2.22B-32.01M-133.07M635.7M-749.55M713.21M1.5B566.4M-8.97M62.9M14.95M152.82M-8.84M-17.52M224.1M131.95M-286.84M-368.43M0000000
Equity Issued (Net)-1B-406.34M-1.45B-1.12B-389.79M116.6M-194.56M-597.8M-500.78M-227.01M168.9M-1.85B-626.02M-328.46M-1.05B-685.05M-337.64M-428.28M-596.22M-1.34B-581.2M-613.7M00000000
Dividends Paid-476.81M-437.08M-416.17M-398.75M-391.69M-366.65M-343.58M-338.97M-333.04M-320.27M-288.48M-253.92M-214.47M-195.72M-132.76M-117.62M-90.62M-62.7M-48.67M-37.25M-20.59M-10.6M-11.2M-10.99M-10.5M00000
Share Repurchases-1B-435.47M-1.49B-1.18B-483.7M-82.15M-420.45M-674.03M-639.24M-329.93M-2.27B-2.04B-753.93M-484.18M-1.16B-840.58M-470.36M-450.35M-680.62M-1.44B-719.25M-787.76M-145.69M0000-400K00
Other Financing-118.5M-103.14M-75.85M-80.69M-48.2M-13.65M-33.47M-16.67M-44.75M-15.98M-28.57M-27.64M-227.4M-207.83M000-4.34M-163K00-18.86M-131.93M-5.32M43.1M99.32M-133.77M24.8M-129.4M148.7M
Net Change in Cash576.94M1.1B544.99M-840.65M523.41M-1.53B1.22B881.68M57.4M-321.85M574.39M358.93M577.51M164.4M-759.38M167.81M648.81M131.25M237.91M-621.06M294.71M444.34M71.31M136.7M365.71M176.81M61.32M11M-11.6M-5.5M
Free Cash Flow3.88B3.21B3B3.45B2.21B2.23B1.84B2.03B1.07B1.02B2.71B3.69B1.2B585.67M1.14B999.99M923.99M637.93M599.76M1.09B694.13M1.32B635.8M264.26M471.77M-63.37M199.96M-12.8M115.5M-25.2M
FCF Margin %1.15%1%1.02%1.32%0.92%1.04%0.97%1.13%0.64%0.67%1.85%2.71%1%0.67%1.44%1.25%1.19%0.89%0.85%1.65%1.13%2.42%1.2%0.53%1.04%-0.39%1.72%-0.13%1.33%-0.32%
FCF Growth %21%6.99%-13.19%56.47%-0.97%21.28%-9.66%89.19%5.12%-62.32%-26.43%207.73%104.67%-48.69%14.14%8.23%44.84%6.36%-44.97%57.01%-47.54%108.12%140.6%-43.98%844.5%-131.69%1662.2%-111.08%558.33%-203.7%
FCF per Share19.9916.4314.9716.8810.4510.698.979.604.884.6112.0116.945.092.494.443.603.222.111.852.901.673.071.350.571.05-0.250.96-0.060.57-0.13
FCF Conversion (FCF/Net Income)1.37x2.49x2.31x2.24x1.59x1.73x-0.65x2.74x0.85x3.59x2.23x-29.06x5.29x1.82x1.82x1.65x1.74x1.56x2.94x2.57x1.73x4.78x1.76x0.80x1.55x-0.32x2.19x0.04x2.49x-0.20x
Interest Paid000000000000000000000000000000
Taxes Paid000000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Negative operating cash flow volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Cash Conversion Swings Between Extremes

According to the reported quarterly figures, Cencora's operating cash flow to net income ratio ranged from negative 9.22 to 295.80 over ten quarters, indicating that cash conversion is driven more by working capital timing than by underlying earnings quality.

The most striking pattern is that quarters with negative operating cash flow, such as 2026Q1 at negative $2.3B and 2025Q1 at negative $2.7B, coincide with large working capital outflows of $3.4B and $3.6B respectively. This suggests that reported net income is not reliably translating into cash, and investors should monitor whether these swings reflect seasonal receivables timing or a more persistent drag. The near-zero or negative net income quarters combined with positive operating cash flow in other periods further indicate that the ratio is not a stable diagnostic at this margin level.

Free Cash Flow Lumpy and Working-Capital Dependent

Based on reported figures, Cencora's free cash flow margin oscillated between negative 3.5 percent and positive 4.3 percent, with the sign of each quarter tracking working capital movements more closely than reported profitability.

Free cash flow of $3.2B in 2025Q2 and $2.9B in 2025Q4 contrasts sharply with the negative $2.8B in 2025Q1, and the swing appears driven by working capital changes of $2.2B and negative $3.6B respectively. Capital expenditure remained modest at roughly 0.1 to 0.3 percent of revenue, so the volatility is not attributable to investment intensity. Investors should treat trailing free cash flow with caution until the working capital pattern shows clearer persistence.

Working Capital Drives Quarterly Cash Outcomes

As reported in the financial statements, changes in working capital ranged from negative $3.6B to positive $2.2B across recent quarters, a magnitude that exceeds net income in most periods and largely determines reported operating cash flow.

The scale of working capital movements relative to net income of roughly $0.5B to $0.8B per quarter suggests that receivables, inventory, and payables timing dominates the cash outcome for this distributor. Persistent outflows in early-year quarters may reflect seasonal rebuilding of inventory or receivable build-up, though the data alone cannot confirm the cause. Investors should monitor days sales outstanding and payables terms in upcoming filings to determine whether the pattern is structural or cyclical.

Dividend Steady While Acquisitions Absorb Cash

Based on Cencora's reported figures, dividend payments held near $107M to $126M per quarter while acquisition outflows reached $4.7B in 2026Q2, suggesting that discretionary deployment has been dominated by M&A rather than shareholder returns.

The stability of quarterly dividends at roughly $110M alongside buybacks that were largely absent in recent quarters implies a priority on balance sheet flexibility rather than capital return expansion. The $4.7B acquisition outflow in 2026Q2 appears consistent with the OneOncology transaction referenced in recent context, though the reported data does not isolate its return profile. Given the reported debt-to-equity ratio of 6.15, the sustainability of this deployment pattern warrants close monitoring.

Cash Flow Quality Obscured by Adjustments

Reported stock-based compensation and depreciation add-backs of $20M to $127M per quarter appear modest relative to operating cash flow swings, but the cash flow statement may not fully reflect opioid litigation outflows or LIFO-related timing effects.

The provided data does not disclose the timing or magnitude of opioid settlement cash payments, which analysts have historically treated as excluded from adjusted earnings yet material to free cash flow. Because LIFO accounting can shift cost of goods sold during price volatility, the operating cash flow figures may embed non-cash inventory effects that are not separately quantified here. These limitations mean the cash conversion picture should be treated as indicative rather than conclusive until segment and footnote detail is reviewed.

COR — Frequently Asked Questions

Quick answers to the most common questions about buying COR stock.

How much cash does Cencora, Inc. (COR) generate from operations?

Cencora, Inc. (COR) generated $4.79B in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Cencora, Inc.'s free cash flow?

Cencora, Inc. (COR) generated $3.88B in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cencora, Inc.'s capital expenditure (CapEx)?

Cencora, Inc. (COR) spent $909.5M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Cencora, Inc. distribute cash to shareholders?

In 2026, Cencora, Inc. (COR) returned $476.8M to shareholders via cash dividends and spent $1.00B on share repurchases. This shows the company's commitment to returning capital to its equity investors.